Shiga Toxin Producing E coli STEC for FRCPath Definition Pathogenesis Diagnosis and Exam Tips
A child with bloody diarrhoea, little or no fever, and rising creatinine is an exam scenario until proven otherwise. For medical microbiology, that scenario should trigger one organism group straight away: Shiga toxin-producing Escherichia coli.
This topic matters because the organism is common enough to appear in real diagnostic work, serious enough to cause haemolytic uraemic syndrome, and nuanced enough to test judgement. The FRCPath angle is rarely just “name the bug”. Expect questions on toxin biology, laboratory detection, antibiotic avoidance, outbreak control, and when to involve public health.
This article is for exam preparation and professional education. It is not a substitute for local clinical guidelines or specialist advice in patient care.
What is Shiga toxin producing E coli and why does it matter
Shiga toxin-producing E. coli are strains of Escherichia coli that produce Shiga toxins, usually encoded by bacteriophages carrying `stx` genes. The group includes the classic enterohaemorrhagic E. coli phenotype, often called EHEC, but the terms are not perfectly interchangeable.
A practical exam definition is:
Shiga toxin-producing E. coli are diarrhoeagenic E. coli that produce Shiga toxin 1, Shiga toxin 2, or both, and can cause haemorrhagic colitis and haemolytic uraemic syndrome.
The best-known serotype is E. coli O157:H7, but non-O157 strains are clinically important. Examples include O26, O45, O103, O111, O121 and O145. In many modern laboratories, molecular testing detects the toxin genes before the serotype is known. This is a key FRCPath point because a culture strategy aimed only at O157 can miss non-O157 disease.
Why the organism is significant
STEC is important for five linked reasons.
It can cause severe disease after a low infectious dose.
It spreads through food, water, animals, the environment, and person-to-person transmission.
Antibiotics and antimotility agents may worsen outcomes in some cases.
Cases may signal a wider outbreak.
Severe complications can appear after the diarrhoeal illness starts to improve.
Cattle and other ruminants are major reservoirs. They often carry the organism asymptomatically. Human infection follows exposure to contaminated food such as undercooked beef, unpasteurised milk, contaminated fresh produce, or untreated water. Direct contact with farm animals and their environment also matters, especially for children.
For FRCPath purposes, remember the exam answer is not limited to “food poisoning”. The correct clinical microbiology response includes risk assessment, laboratory confirmation, infection prevention, public health notification, and follow-up for HUS.
How STEC causes disease
The pathogenesis of STEC combines colonisation, toxin production, epithelial injury, and systemic endothelial damage. The strain’s virulence depends on its toxin genes and accessory factors, not just its O serogroup.
Shiga toxin genes are bacteriophage encoded
Shiga toxins are encoded by `stx1` and `stx2` genes carried on lysogenic bacteriophages. Phage biology matters because induction of the phage lytic cycle can increase toxin production. This point underpins the concern about antibiotics, especially agents that may induce bacterial stress responses.
There are two major toxin types.
Toxin | Key exam points |
Stx1 | Closely related to Shiga toxin of Shigella dysenteriae type 1. Often associated with disease, but generally less strongly linked with HUS than Stx2. |
Stx2 | More heterogeneous, with several subtypes. Stx2, especially some subtypes, is more strongly associated with severe disease and HUS. |
Stx1 and Stx2 together | Co-presence may occur. Clinical severity depends on subtype, host factors, bacterial background, and exposure. |
A neat viva answer should mention both toxin types and state that Stx2 is the stronger red flag for HUS risk.
Shiga toxin has an AB5 structure
Shiga toxin is an AB5 toxin.
The B subunits bind host cell receptors.
The A subunit enters the cell and acts as an N-glycosidase.
It removes a specific adenine from 28S rRNA in the 60S ribosomal subunit.
This blocks protein synthesis and triggers cell injury.
The main receptor is globotriaosylceramide, also known as Gb3. Gb3 expression on renal glomerular endothelial cells helps explain the kidney injury in HUS. Endothelial damage leads to platelet activation, microthrombi, red cell fragmentation, and acute kidney injury.
This links directly to the clinical triad:
Microangiopathic haemolytic anaemia
Thrombocytopenia
Acute kidney injury
Attachment and effacement help intestinal colonisation
Many STEC strains carry the locus of enterocyte effacement, often shortened to LEE. This pathogenicity island encodes a type III secretion system and proteins that create attaching and effacing lesions.
A key adhesin is intimin, encoded by `eae`.
The bacterium attaches closely to intestinal epithelial cells, effaces microvilli, and disrupts absorptive surfaces. This contributes to diarrhoea and intestinal inflammation. Some STEC strains are LEE-negative and use other adhesins, so absence of `eae` does not exclude pathogenic potential.
For exam answers, use this structure:
Ingestion of organism from contaminated source.
Survival through gastric acid and colonisation of the colon.
Attachment to epithelium, often with attaching and effacing lesions.
Production and release of Shiga toxin.
Toxin entry into the circulation.
Endothelial injury, especially renal microvasculature.
HUS in susceptible cases.
Clinical manifestations and associated diseases
The incubation period is usually a few days, often around 3 to 4 days, but it can vary. The clinical picture ranges from asymptomatic carriage to severe colitis and HUS.
Uncomplicated diarrhoeal illness
Early symptoms may include:
Abdominal cramps
Watery diarrhoea
Nausea or vomiting
Low-grade fever or no fever
Fever is often absent or mild. This is useful in exams because high fever may suggest invasive bacterial dysentery such as Shigella, Campylobacter, Salmonella, or enteroinvasive E. coli, though real cases overlap.
Haemorrhagic colitis
The classic presentation is severe abdominal pain with bloody diarrhoea. The stool may become visibly bloody after an initial watery phase. Patients may look less systemically toxic than expected for the degree of bloody diarrhoea.
Colitis can mimic surgical pathology or inflammatory bowel disease. Severe cases may develop complications such as toxic megacolon or bowel ischaemia, although these are less common than HUS.
Haemolytic uraemic syndrome
HUS is the major feared complication. It usually appears several days after diarrhoea begins, often when the gut symptoms are improving.
The classic triad is:
Microangiopathic haemolytic anaemia
Thrombocytopenia
Acute kidney injury
Blood film may show fragmented red cells. Lactate dehydrogenase rises due to haemolysis. Creatinine rises with renal involvement. Urinalysis may show haematuria or proteinuria.
Children and older adults are at higher risk of severe disease. HUS after diarrhoea is sometimes called typical HUS, in contrast to complement-mediated atypical HUS. That terminology can appear in exams, but the key microbiology distinction is stool evidence of Shiga toxin or `stx` genes.
Neurological and systemic complications
Severe cases can involve the central nervous system, with seizures, reduced consciousness, or stroke-like features. Pancreatitis, myocardial involvement, and severe hypertension may also occur. These are not the first facts to give in a short-answer question, but they are useful in viva discussion of severe HUS.
Differential diagnosis in the exam
Bloody diarrhoea has a broad differential. In a microbiology exam, compare the main causes by clinical pattern and test choice.
Cause | Clues | Diagnostic approach |
STEC | Bloody diarrhoea, severe cramps, little fever, HUS risk | Stool PCR or toxin assay, culture and reference typing |
Shigella | Fever, tenesmus, dysentery, person-to-person spread | Stool culture or molecular panel |
Campylobacter | Fever, abdominal pain, sometimes pseudoappendicitis | Stool culture or molecular test |
Non-typhoidal Salmonella | Food exposure, fever, diarrhoea | Stool culture |
Amoebiasis | Travel or exposure risk, prolonged dysentery | Microscopy, antigen, PCR, serology where relevant |
Inflammatory bowel disease | Chronic or relapsing symptoms | Clinical, endoscopic, histological assessment |
Diagnosis and laboratory identification
Diagnosis has changed. Older approaches relied heavily on identifying O157 using sorbitol MacConkey agar. Modern practice increasingly uses molecular or immunological detection of Shiga toxin or its genes, followed by culture for isolate recovery and typing.
An FRCPath answer should separate front-line detection from public health characterisation.
Specimen choice and timing
The key specimen is stool. If stool is not available, a rectal swab may be used, depending on local policy and the testing platform.
Early sampling improves diagnostic yield. Laboratories should be told if STEC is suspected, especially in bloody diarrhoea, HUS, food handler cases, nursery outbreaks, or farm exposure. Clinical details can change which tests are done and how quickly public health action begins.
Direct detection of toxin or toxin genes
Common front-line methods include:
Nucleic acid amplification tests for `stx1` and `stx2`
Multiplex gastrointestinal PCR panels
Enzyme immunoassays for Shiga toxin
Reflex culture after a positive toxin or gene result
PCR detects genes, not necessarily active toxin expression. Toxin immunoassays detect toxin antigen, but performance varies by assay and organism burden. In practice, laboratories often use algorithms combining molecular detection, culture, and reference testing.
A high-quality report should avoid overclaiming. For example:
“Shiga toxin gene detected” is not the same as “O157 isolated”.
“O157 not isolated” does not exclude non-O157 STEC if `stx` is present.
A positive `stx` result should prompt public health and infection control consideration while culture confirmation proceeds.
Culture methods
For O157, sorbitol MacConkey agar is classically useful because many O157:H7 strains do not ferment sorbitol. Cefixime tellurite sorbitol MacConkey agar improves selectivity.
Typical O157 on sorbitol MacConkey:
Non-sorbitol fermenting colonies
Colourless or pale colonies against a background of sorbitol fermenters
Confirmation by biochemical identification and O157 antisera or molecular methods
This is a classic exam fact, but it has a trap. Not all STEC are O157, and not all O157 behave perfectly. Sorbitol-based culture alone is not enough for modern detection.
Non-O157 STEC may look like ordinary E. coli on routine media. Detection usually depends on toxin gene testing, immunomagnetic separation for selected serogroups, serotyping, or reference laboratory methods.
Serotyping and virulence profiling
Serotyping identifies O and H antigens, such as O157:H7 or O26:H11. Virulence profiling may include detection of:
`stx1`
`stx2`
`eae`
`ehxA`, encoding enterohaemolysin in some strains
Whole genome sequencing is now widely used in reference and public health contexts. It can support outbreak detection, cluster analysis, virulence prediction, and antimicrobial resistance assessment. In an FRCPath answer, it is fair to say WGS helps determine relatedness between isolates during outbreaks, rather than quoting specific thresholds.
Reference laboratory role
Reference laboratories can confirm the organism, determine serotype, detect toxin subtype, and compare isolates during outbreak investigations. In the UK, suspected or confirmed cases with public health significance are managed with local health protection teams and specialist reference services according to current pathways.
Do not wait for final serotyping before escalating a high-risk scenario. Bloody diarrhoea in a child with a positive `stx2` PCR is enough to trigger urgent clinical and public health thinking.
A practical diagnostic algorithm
A concise exam algorithm could look like this:
Receive stool from patient with bloody diarrhoea or suspected HUS.
Perform molecular gastrointestinal panel or targeted `stx1` and `stx2` testing.
Culture stool, including media or methods suitable for O157 where relevant.
If `stx` positive, attempt isolation of organism.
Send isolate or positive specimen to reference laboratory as per local policy.
Notify appropriate public health teams.
Advise on infection control, exclusion, and household risk assessment.
This shows the examiner that diagnosis is not a single test. It is a chain of actions.
Treatment and clinical management
Treatment is mainly supportive. The microbiology advice matters because some intuitive interventions may increase risk.
Supportive care is the mainstay
Core management includes:
Oral or intravenous rehydration
Monitoring fluid balance
Checking full blood count, urea and electrolytes, creatinine, lactate dehydrogenase, and blood film if HUS is suspected
Early paediatric, renal, or intensive care involvement for severe disease
Avoiding dehydration, which is associated with worse renal outcomes in diarrhoeal illnesses
Patients with HUS may need renal replacement therapy, blood pressure control, red cell transfusion, and specialist renal care. Platelet transfusion is usually avoided unless there is significant bleeding or an invasive procedure, because thrombocytopenia reflects thrombotic microangiopathy rather than simple platelet lack.
Antibiotics are usually avoided
Antibiotic use in suspected or confirmed STEC infection is generally avoided unless a specialist team identifies a compelling reason. The concern is that some antibiotics may induce phage activity, increase Shiga toxin release, and raise HUS risk. Evidence varies by drug class, strain, timing, and clinical setting, but the exam-safe principle is clear:
In suspected STEC with bloody diarrhoea, do not give empirical antibiotics without careful specialist discussion.
This is especially relevant when the patient is afebrile with severe cramps and bloody diarrhoea. Empirical treatment intended for invasive bacterial dysentery may be harmful if the illness is STEC.
Antimotility agents should be avoided
Agents such as loperamide are avoided because reduced intestinal motility may prolong toxin exposure and worsen disease. This is a standard public health and clinical teaching point.
What about eculizumab
Eculizumab inhibits complement and is used in complement-mediated atypical HUS. Its role in STEC-HUS is not routine. It has been used in selected severe cases, especially with neurological involvement, but evidence has not established it as standard treatment for typical STEC-HUS. In exams, frame it as specialist-led and case-dependent, not first-line microbiology advice.
Infection control in healthcare
Patients with diarrhoea need enteric precautions. Measures include:
Single room isolation where possible
Gloves and aprons for contact with stool or contaminated surfaces
Handwashing with soap and water, especially because alcohol gel is not enough for visibly soiled hands
Enhanced environmental cleaning
Clear advice before discharge
For healthcare settings, the significance extends beyond the index patient. A missed case can expose vulnerable patients, staff, and household contacts.
Public health implications
Every case should prompt a source and transmission assessment. The public health response aims to prevent secondary cases and identify outbreaks early.
Transmission routes
Important routes include:
Undercooked minced beef or other contaminated meat
Unpasteurised milk or dairy products
Contaminated salad vegetables or fruit
Untreated private water supplies
Petting farms and animal contact
Person-to-person spread in households, nurseries, and care settings
Recreational water exposure
The low infectious dose means small lapses in hygiene can matter. This is why childcare settings, food handlers, and carers receive close attention.
Notification and exclusion
In the UK, suspected food poisoning and infectious diseases of public health importance require appropriate notification under national and local arrangements. Labs also report relevant organisms through established surveillance routes. Local health protection teams guide exclusion and clearance requirements.
High-risk groups may need exclusion from work, school, nursery, or care duties until criteria are met. These groups often include:
Food handlers
Healthcare workers involved in direct patient care
Nursery or preschool children
Staff or attendees in settings with vulnerable people
People who cannot maintain good personal hygiene
Exact exclusion rules can change and vary by jurisdiction, so quote local guidance in practice. In an exam, say you would inform the health protection team and follow current UK public health guidance.
Outbreak investigation
When cases cluster, investigation includes epidemiological and laboratory work.
Public health teams may:
Interview cases about food, water, travel, animal contact, and household exposure
Identify common exposures
Arrange testing for symptomatic contacts
Coordinate environmental health inspection
Trace implicated foods
Use typing or WGS to assess whether isolates are related
Issue control advice to settings such as nurseries or farms
Microbiology contributes by rapid detection, isolate recovery, storage, typing, and clear communication of uncertainty.
Common FRCPath questions and how to answer them
A good STEC answer is structured, cautious, and practical. The examiner is often testing whether microbiology knowledge changes patient management.
Define STEC and name important serotypes
A strong answer:
“STEC are E. coli strains that produce Shiga toxin 1, Shiga toxin 2, or both. The toxin genes are usually phage encoded. O157:H7 is the classic serotype, but non-O157 serogroups such as O26, O103, O111, O121 and O145 also cause severe disease.”
Add that toxin detection is more important than assuming O157.
Explain the pathogenesis of HUS
Use a chain:
“Ingested organism colonises the colon, often with attaching and effacing lesions mediated by LEE and intimin. It produces Shiga toxin, especially Stx2 in severe cases. Toxin binds Gb3 on endothelial cells, inhibits protein synthesis, and causes endothelial injury. This leads to thrombotic microangiopathy, haemolysis, thrombocytopenia, and acute kidney injury.”
That answer links microbiology to pathology and clinical disease.
Why are antibiotics avoided
Say:
“Some antibiotics may induce bacteriophage-mediated toxin production or toxin release. Observational evidence links antibiotic exposure in STEC, especially O157 and Stx2-associated disease, with increased HUS risk. Management is supportive unless a specialist indication exists.”
Avoid saying antibiotics are “always contraindicated” in every possible situation. Exams reward safe nuance.
How would you diagnose STEC in the laboratory
A complete short answer:
“Test stool for `stx1` and `stx2` by PCR or use a validated Shiga toxin assay. Culture for O157 using sorbitol MacConkey or selective media, but do not rely on this alone because non-O157 STEC may be missed. Attempt isolate recovery from positive samples, then send for reference confirmation, serotyping, toxin subtype testing, and outbreak comparison such as WGS.”
What would you do with a positive `stx` result
Include both clinical and public health action:
Inform the clinical team urgently.
Advise supportive care and avoidance of antibiotics and antimotility agents unless specialist-led.
Assess for HUS with blood tests and renal function.
Initiate infection control precautions.
Notify public health or health protection team according to local policy.
Send isolate or specimen for reference testing.
Consider high-risk contacts and settings.
Why can sorbitol MacConkey miss cases
Because sorbitol MacConkey mainly helps detect typical non-sorbitol-fermenting O157. Non-O157 STEC often ferments sorbitol and appears like commensal E. coli. Some O157 strains may also show atypical behaviour. Modern detection should target toxin or toxin genes.
What distinguishes STEC from enterotoxigenic E coli
Enterotoxigenic E. coli causes traveller’s diarrhoea through heat-labile and heat-stable enterotoxins. It causes watery diarrhoea, not classically bloody colitis or HUS. STEC produces Shiga toxin and can cause haemorrhagic colitis and HUS.
What is the difference between EHEC and STEC
STEC is defined by Shiga toxin production. EHEC is a clinical or pathogenic subset associated with haemorrhagic colitis and often attaching and effacing lesions. Many examiners use the terms loosely, but the precise distinction is worth stating.
High-yield facts to remember
For rapid revision, keep these facts close.
Topic | High-yield fact |
Reservoir | Cattle and other ruminants |
Infectious dose | Low, so person-to-person spread and environmental exposure matter |
Classic serotype | O157:H7 |
Non-O157 disease | Clinically important and missed by O157-only methods |
Major toxins | Stx1 and Stx2 |
Greater HUS association | Stx2, especially certain subtypes |
Toxin structure | AB5 toxin |
Cellular target | 28S rRNA in 60S ribosomal subunit |
Receptor | Gb3 |
Key complication | HUS |
Classic HUS triad | Anaemia, thrombocytopenia, acute kidney injury |
Classic culture clue | O157 often does not ferment sorbitol |
Best modern screen | `stx1` and `stx2` detection or validated toxin assay |
Treatment | Supportive care |
Avoid | Antibiotics and antimotility agents unless specialist-led |
Public health | Notify, exclude high-risk cases when required, investigate sources |
Exam pitfalls that cost marks
Many candidates know the organism but lose marks on the practical details.
Pitfall one is treating O157 as the whole topic
O157 is important, but non-O157 STEC causes severe illness. Always mention toxin-based detection.
Pitfall two is forgetting public health
A positive result is not just a lab finding. It may represent a nursery outbreak, a contaminated food product, or a farm exposure cluster.
Pitfall three is recommending empirical ciprofloxacin
For bloody diarrhoea this can be tempting, especially when thinking of invasive bacterial infection. In suspected STEC, antibiotics need specialist review because of possible HUS risk.
Pitfall four is missing HUS monitoring
The diarrhoea may improve before renal disease becomes obvious. Patients need safety-netting and appropriate blood tests when risk is present.
Pitfall five is overinterpreting PCR
PCR for `stx` detects genes. Culture and reference testing still matter for confirmation, typing, and outbreak work.
Final takeaway
STEC is an exam favourite because it connects molecular microbiology with bedside decisions. The best answer starts with toxin definition, explains phage-encoded Stx1 and Stx2, links Gb3-mediated endothelial injury to HUS, and chooses diagnostic tests that detect both O157 and non-O157 strains.
For FRCPath, the safest mental model is simple: bloody diarrhoea plus little fever means think STEC, test for Shiga toxin genes, avoid antibiotics and loperamide, monitor for HUS, and involve public health early.
Comments